InvaGen Pharmaceuticals Inc. 13D and 13G filings for Avenue Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-19 07:26 am Sale | 2022-10-11 | 13D | Avenue Therapeutics, Inc. ATXI | InvaGen Pharmaceuticals Inc. | 0 0.000% | -9,476 (Position Closed) | Filing |
| 2022-07-28 4:30 pm Purchase | 2022-07-25 | 13D | Avenue Therapeutics, Inc. ATXI | InvaGen Pharmaceuticals Inc. | 9,476 46.950% | 533 (+5.96%) | Filing |